Skip to content
New issue

Have a question about this project? Sign up for a free GitHub account to open an issue and contact its maintainers and the community.

Sign up for GitHub

By clicking “Sign up for GitHub”, you agree to our terms of service and privacy statement. We’ll occasionally send you account related emails.

Already on GitHub? Sign in to your account

Jump to bottom

Add name into participant list in about.md #14

Merged
merged 1 commit into from
Jul 26, 2024
Merged

Add name into participant list in about.md #14

Changes from all commits
Commits
Show all changes
1 commit
Select commit
File filter

Filter by extension

Filter by extension
Conversations
Failed to load comments.
Jump to
Jump to file
Failed to load files.
Diff view
Diff view
4 changes: 2 additions & 2 deletions app/www/static/about.md
View file
Open in desktop
Original file line number Diff line number Diff line change
Expand Up @@ -21,7 +21,7 @@ A team at
<a href="https://appsilon.com" target="_blank">Appsilon</a>
adapted the pilot Shiny application to use the <a href="https://appsilon.github.io/rhino/" target="_blank">Rhino</a> framework bringing enterprise features to this application.

Among the participants are Ning Leng _(Roche)_, Heng Wang _(Roche)_, Mike Stakehouse _(Atorus)_, Eli Miller _(Atorus)_, Yilong Zhang _(Merck)_, Gregery Chen _(Merck)_ and Eric Nantz _(Eli Lilly)_. Paul Schuette and Hye Soo Cho from FDA are also participating in this working group.
Among the participants are Ning Leng _(Roche)_, Heng Wang _(Roche)_, Mike Stakehouse _(Atorus)_, Eli Miller _(Atorus)_, Yilong Zhang _(Merck)_, Gregery Chen _(Merck)_, Eric Nantz _(Eli Lilly)_, and Sam Parmar _(Pfizer)_. Paul Schuette and Hye Soo Cho from FDA are also participating in this working group.

The full list is publicly available at the
<a href="https://rconsortium.github.io/submissions-wg/pilot2.html" target="_blank">Pilot&nbsp;2 page</a>.
Expand Down Expand Up @@ -65,4 +65,4 @@ A summary table of an additional efficacy analysis is shown for baseline and wee

A summary table of the number of patients remaining in the treatment period for each scheduled visit from baseline to week 24.

###
###